Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Crescent Biopharma Inc.

    NASDAQ: CBIO · Real-Time Price · USD
    13.70
    -0.09 (-0.65%)
    At close: Aug 18, 2025, 10:46 AM

    Crescent Biopharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025
    Period Ending Jun 30, 2025
    Revenue
    		 n/a
    Cost of Revenue
    		 n/a
    Gross Profit
    		 n/a
    Operating Income
    		 -21.03M
    Interest Income
    		 313K
    Pretax Income
    		 -21.79M
    Net Income
    		 -21.79M
    Selling & General & Admin
    		 8.95M
    Research & Development
    		 12.08M
    Other Expenses
    		 n/a
    Operating Expenses
    		 21.03M
    Interest Expense
    		 1.07M
    Selling & Marketing Expenses
    		 n/a
    Cost & Expenses
    		 21.03M
    Income Tax Expense
    		 n/a
    Shares Outstanding (Basic)
    		 864.21K
    Shares Outstanding (Diluted)
    		 1.02M
    EPS (Basic)
    		 -25.21
    EPS (Diluted)
    		 -21.37
    EBITDA
    		 -20.72M
    EBIT
    		 -20.72M
    Depreciation & Amortization
    		 n/a

    Add to Watchlist